<DOC>
	<DOCNO>NCT01914081</DOCNO>
	<brief_summary>The purpose study determine resveratrol improve heart function quality life . Although , population study reveal mild moderate intake red wine reduces cardiovascular disease risk human , clinical study evaluate potential heart benefit resveratrol patient non-ischemic cardiomyopathy previously report . Accordingly , research do fill deficiency information available literature establish clinical benefit resveratrol patient type heart disease .</brief_summary>
	<brief_title>Resveratrol : Potential Anti-remodeling Agent Heart Failure , From Bench Bedside</brief_title>
	<detailed_description>The investigator conduct randomize double blind placebo control study 40 adult ( â‰¥18 90 year old ) . Twenty ( 20 ) subject include placebo arm , 20 treatment arm . Patients randomly allocate receive placebo resveratrol . After randomization , two group subject follow exactly way , difference care receive intrinsic treatment compare . The randomization minimize allocation bias , balance know unknown prognostic factor , assignment treatment .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Resveratrol</mesh_term>
	<criteria>Subjects ( 1890 year age ) nonischemic cardiomyopathy , systolic dysfunction ( define Left Ventricular Ejection Fraction ( LVEF ) &lt; 40 % ) New York Heart Association ( NYHA ) Functional class IIIII ( mildmoderate heart failure symptom ) On optimal medical management 6 month per standard care Normal sinus rhythm Ischemic cardiomyopathy Severe valvular cardiomyopathy No surgical intervention plan past 6 month Subjects amiodarone , statin diltiazem ( calcium channel blocker ) Patients history serious hypoglycemia require hospitalization hyperglycemic emergency require hospitalization past 6 month Subjects anticoagulant , Coumadin , dabigatran Subjects HIV protease inhibitor ( saquinivir ) , immunosuppressant ( cyclosporine , tacrolimus ) Subjects antihistamine ( terfenadine ) , benzodiazepine ( midazolam , triazolam ) Subjects sildenafil drug use treat erectile dysfunction Cardiac resynchronization therapy Chronic renal insufficiency Known liver cirrhosis Wide QRS complex width &gt; 120 m Other significant comorbidity e.g . cancer affect ability complete study Pregnant lactate woman Subjects estrogen contain birth control</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Non-ischemic cardiomyopathy</keyword>
	<keyword>Resveratrol</keyword>
</DOC>